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iPoster session: Left ventricular function - Heart failure
in 60 (43%) patients showing HbA1c greater than or equal to 8
(uncontrolled diabetes), normal function was found in 36 and dias-
tolic dysfunction in 24, with a signiﬁcant difference of BNP at
multivariate analysis (OR = 1.03, 95%CI = 1.04—1.09, P = 0.002). In
uncontrolled diabetic cohort, BNP was a strong predictor for LVDD
(OR = 3.1, 95%CI = 1.5—6.1, P = 0.004) along with the duration of dia-
betes (OR = 2.1, 95%CI = 1.3—3.2, P = 0.034). BNP > 25pg/mL was a
cut-off value with high accuracy to detect a LVDD.
Conclusions.— BNP could be a cheap, easy and useful tool to screen
patients with preclinical ventricular diastolic dysfunction among
those particularly prone to develop cardiovascular complications,
such as uncontrolled diabetic patients.
doi:10.1016/j.acvd.2011.03.026
What are particularities in echocardiography and Doppler of
diabetics with chronic heart failure?
M.-K. Benjelloun , S. Hajib , N. Yamoul , Z. El Honsali , A. Bennis
Département de cardiologie, CHU Ibn Rochd, Casablanca, Morocco
Introduction.— The prevalence of heart failure and diabetes are
both increasing: 25 to 30% of patients with heart failure suffer
from diabetes. Diabetics have more diastolic dysfunction because
accumulation collagen in intramyocardial.
The objectives of our study are to compare echocardiographics and
Doppler proﬁles of diabetics and non-diabetics.
Patients and methods.— We included 1351 patients, diabetics and
non-diabetics, admitted in united of heart failure in our Center
of Cardiology from May 2006 to October 2010. All patients were
evaluated by echocardiography and Doppler.
The data are presented as numbers, percentages, and medians
with interquartile range. The distribution of variables was com-
pared between diabetics and non diabetics by Chi-square test with
conﬁdence intervals.
Results.— One thousand three hundred and ﬁfty-one patients
were studied, the median age was 63 years. Three hundred and
sixty-seven (27%) are diabetics. Overall, it exists similarity of
the parameters studied between the 2 groups diabetics and non-
diabetics in terms of morphology and hemodynamics (end diastolic
left ventricle volume; mitral regurgitation; interventricular septum
size; pulmonary arterial systolic pressure; left atrial volume. . .). But
we have found important differences of 3 parameters: ejection frac-
tion of left ventricle was higher (48,5% and 35%) in diabetics group.
We found more segmental kinetic disorders (76% and 50%) and more
diastolic dysfunction with higher ﬁlling pressures (51% and 34%) in
diabetic population.
Conclusion.— So, in our study, we have found more diastolic dys-
function and more segmental kinetic disorders but ejection fraction
of left ventricle is higher in patients diabetics with chronic heart
failure. In general, our results were consistent with most of the
European and American studies.
These ﬁndings emphasize the importance of individualised manage-
ment and need for more comprehensive recruitment of diabetics in
clinical trials.
doi:10.1016/j.acvd.2011.03.027
Serial measurements of NT-proBNP are predictive of non-high
dose anthracycline cardiotoxicity in breast cancer patients
F. Simona
Cardiology, Univesity of L’Aquila, Coppito-L’Aquila, Italy
Background.— A well-known side effect of anthracycline’s
chemotherapy is cardiotoxicity. It consists in developing a dose-
dependent cardiomyopathy with an incidence ranging from 2 to 20%.
Assessment of biohumoral markers may be useful in early detection
of subjects at high risk of developing cardiotoxicity, as demon-
strate by studies carried out in patients undergoing a high-dose
chemotherapy. However, there are few studies considering both the
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easurement of natriuretic peptides and not-high-dose protocol of
hemotherapy.
im.— The aim of the study was to evaluate the possibility of
arly detection of subjects at high-risk for developing left ventricu-
ar dysfunction in breast cancer patients undergoing non-high-dose
hemotherapy (NHDC).
ethods and results.— In 71 patients treated with anthracycline NT-
roBNP, CK-MB and cardiac Troponin I (cTnI) were evaluated before
ach drug administration and 24 hours after. Left ventricular dimen-
ion/function was assessed by echocardiography at baseline, every
wo cycles, at the end of chemotherapy, 3, 6 and 12months during
he follow-up. NT-proBNP, CK-MB and cTnI values were normal at
aseline in all the patients. Throughout the chemotherapy, CK-MB
ere normal, cTnI was abnormal only occasionally in 4 patients,
T-proBNP showed abnormal values. According to these NT-proBNP
odiﬁcations, the patients were divided into 2 groups: group A (50
atients), where normal values (23 cases) or temporary alterations
27 cases; i.e. increase at 24 hours and then decrease to normal
alues) were detected; group B (21 patients) with persistent NT-
ro-BNP abnormalities throughout all the measurements. The Group
showed follow-up left ventricular impairment greater than the
roup A. The percentage difference (baseline-peak) NT-proBNP was
redictive for LV impairment at 3, 6 and 1-year follow-up; per-
entage difference (baseline-peak) NT-proBNP higher than 36% was
redictive for LV impairment at the same follow-up interval times.
onclusions.— Serial evaluation of NT-proBNP may be a useful tool
n order to early detect the patients at high-risk of cardiotoxicity,
mong those treated with NHDC.
oi:10.1016/j.acvd.2011.03.028
ontribution of right ventricular echocardiographic parameters
n evaluation of the prognosis of dilated cardiomyopathy
. Fennira , S. Mahmoud , S. Antit , S. Kammoun , S. Longo , S.
raiem
Department of Cardiology Habib Thamer, Tunis, Tunisia
ntroduction.— The evaluation of the prognosis of patients with
ilated cardiomyopathy (DCM) is an essential step in their care.
oppler echocardiography is a noninvasive, reliable and available
ethod for the diagnosis and also for the prognosis’s study of these
atients. But the study ultrasound of the right ventricle (RV) is not
part of the practice of the cardiologist.
urpose of study.— Determine which of the echocardiographic
arameters that assess systolic and diastolic function of the RV,
hose predicting of the occurrence of secondary cardiac events
death, hospitalization for decompensated heart failure and ven-
ricular arrhythmias poorly tolerated) in patients with DCM.
aterials and methods.— Prospective study in 61 patients with
CM symptomatic heart failure (class II→IV NYHA) who are stable
ith medical treatment. All these patients received a conventional
chocardiographic examination with emphasis on studying the RV
arameters: fractional shortening surface RV (FRSRV), the systolic
xcursion of the tricuspid annulus to the TM (TAPS), and systolic
ulmonary artery pressure (SPAP), that is completed by a study at
issue pulsed Doppler at the tricuspid annulus wave (Sa, Ea and Aa).
ll patients were regularly monitored. We studied the correlation
etween echocardiographic parameters of RV and the occurrence
f secondary cardiac events.
esults.— There were 61 patients in a period from February 2006 to
eptember 2007. The average age of patients was 62± 9.86 years
40 to 81 ans) with a sex-ratio of 2m/1woman. Forty-eight percent
f patients were in NYHA class III. The average fractional ejection of
eft ventricle was 29± 7.2%. DCM was ischemic in 59% of cases. Dur-
ng follow-up (11± 5months), 5 patients died, 22 were hospitalized
or decompensated heart failure and 2 patients had a ventricular
achycardia. We have shown that the parameters predictors of mor-
ality are: TAPS < 12mm and a FRSRV < 33%. Parameters predictive
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f hospitalization for decompensated heart failure: SPAP > 42mm
g, RV FRS < 39%, a TAPS < 15mm and wave velocities Sa, Ea and Aa
r DTI tricuspid annulus < respectively 10.1 cm/s to 6.09 cm/s and
2.75 cm/s. Echocardiographic parameters predictive of cardiac
vents overall were: SPAP > 42mm Hg, a TAPS < 11.5, a FRSRV < 38%,
a and Aa waves to the DTI tricuspid lower respectively at 10.2 cm/s
nd 14 cm/s. In multivariate analysis, only the FRSRV < 38% was a
actor directly related to the occurrence of cardiac events overall.
onclusion.— In current practice, assessment of the prognosis of
atients with DCM is limited to consideration of the left ventri-
le. The evaluation of echocardiographic parameters of systolic and
iastolic RV functions would be very useful for better stratiﬁcation
f prognosis of these patients.
oi:10.1016/j.acvd.2011.03.029
eft atrial volume as a morphophysiologic expression of left
entricular diastolic dysfunction
. Bennour , I. Kammoun , N. Hammami , S. Chine , S. Marrakchi ,
. Chrigui , A. Ben Halima , Z. Ibnelhaj , S. Gargouri , W.
oughanmi , A. Leﬁ , F. Added , S. Kachboura
Department of Cardiology, Ariana Hospital, Ariana, Tunisia
ackground.— Left ventricular (LV) diastolic dysfunction is prevalent
n the community.
revious studies have reported an association between diastolic
unction and atrial dimension.
bjective.— The aim of this study is to evaluate the relation
etween left atrial (LA) volume and LV diastolic function.
ethods and results.— In the present prospective study of 120
dults, mean age 59± 4 years, referred for a clinically-indicated
chocardiogram and in sinus rhythm, with no history of atrial
rrhythmias or valvular heart disease and with an ejection frac-
ion > 50%, we determined the LA volume, LV diastolic function
tatus.
he left atrial volume was calculated from the apical four-chamber
nd two-chamber views at ventricular endsystole with using Simp-
on’s biplane method.
iastolic dysfunction (DD) was found in 72% of classiﬁed patients.
he LA volume indexed to body surface area (LAVi) increased
ith worsening DD: 23.8mL/m2 (normal), 29mL/m2 (grade I),
2.5mL/m2 (grade II) and 51.7mL/m2 (grades III). The LAVi was
trongly associated with diastolic function grade (P < 0.001).
onclusion.— In patients without a history of atrial arrhythmias
r valvular heart disease or an ejection fraction < 50%, LA volume
xpressed the severity of diastolic dysfunction.
oi:10.1016/j.acvd.2011.03.030
ffects of cardiac resynchronization therapy on mitral
egurgitation severity
. Bennour , I. Kammoun , S. Marrakchi , S. Chine , R. Chrigui , A.
enhalima , S. Gargouri , N. Hammami , H. Keskes , A. Leﬁ , F.
dded , S. Kachboura
Department of cardiology, Ariana hospital, Ariana, Tunisia
bjectives.— We studied the effects of cardiac resynchronization
herapy (CRT) on functional mitral regurgitation in heart failure (HF)
atients.
ackground.— Functional mitral regurgitation (FMR) is a common
nding in patients with global left ventricular (LV) dilatation and
ysfunction.
everal recent studies demonstrated that cardiac resynchronization
herapy (CRT) might be able to reduce FMR.
ethods.— Twenty-nine patients with heart failure and FMR were
tudied after implantation of a biventricular CRT system. Clinical
esponders were predeﬁned as survived patients with an improve-
ent by one or more NYHA functional class.
C
f
p19th International Congress of Echocardiography
hanges in FMR severity after CRT were quantiﬁed according to the
roximal isovelocity surface area method by measuring the effec-
ive regurgitant oriﬁce area (EROA) and the regurgitant volume
RV).
esults.— Twenty-nine patients (mean age, 66± 8 years; 26 men;
ean LV ejection fraction 25± 7%) with severe HF were included.
ll patients were restudied at a mean of 8± 2months after CRT; 26
89%) were clinical responders.
ardiac resynchronization therapy was associated with a signif-
cant reduction in FMR severity in clinical responders; effective
egurgitant oriﬁce area (EROA) decreased from 19± 18mm2 to
± 7mm2 (P < 0.001) and regurgitant volume (RV) decreased from
9± 11mL/beat to 10± 9mL/beat (P < 0.001). This was accompa-
ied by a signiﬁcant reduction in LV volumes and an increase in
jection fraction (P = 0.001).
n clinical nonresponders, there was not a signiﬁcant decrease in MR
everity; EROA decreased from 28± 6mm2 to 22± 13mm2 (P = 0.18)
nd RV from 25± 5mL/beat to 22± 8mL/beat (P = 0.18).
onclusion.— Functional mitral regurgitation is reduced in clinical
esponders to CRT. Thus, FMRmay be an important factor inﬂuencing
linical response to CRT.
oi:10.1016/j.acvd.2011.03.031
mpact of betablocker, as a treatment of heart failure, on the
chocardiographic parameters
. Abida, S. Krichènea, Y. Maazounb, H. Mouradb, K. Samirb
Service de cardiologie, FMS, Sfax, Tunisia
Sfax, Tunisia
ntroduction.— Little study analyzed the effect of betablocker on
chocardiographic, functional parameters and the capacity of exer-
ise in case of heart failure.
im.— To analyze the impact of betablocker on several clini-
al, functional, echocardiographic, biochemical parameters, and to
eﬁne predictive factors of improvement.
ethods.— Our study is prospective between August 2009 and
une 2010 including patients followed in cardiology department
f Hédi Chaker hospital for steady heart failure due to left
entricular systolic dysfunction. Patients beneﬁted a clinical,
unctional (NYHA class, TM6M, Minnesota score), echocardio-
raphic assessment and a dosage of the NT-proBNP before
aking bisoprolol, and 3months after the tolerated maximal
ose.
esults.— Forty patients have been included in the study. The mean
ge was of 61,15± 9,86 years, the sex-ratio was 9. The heart fail-
re was ischemic in 70% of cases. The mean dose of bisoporolol
as 5,375± 0,75mg. The tolerance to the betablocker was good
t 70% of patients. A transient aggravation of the effort dyspnea
as been noted at 10% of patients. Only one death occurred in the
utside of the phase of titration. A reduction of the heart rate has
een noted (P = 0, 08). No meaningful elongation of the QRS and
he QT has been noted. The NYHA class (P < 0,001) and the TM6M
mproved of meaningful way (P < 0,001). The left ventricle ejec-
ion fraction (LVEF) improved at 72,5% of patients. The average of
he (LVEF) passed of 29,44± 6,51 to 34,49± 6,9; P < 0,001. Dias-
olic function improved of meaningful way at 33% of patients with
mprovement of the mitral proﬁle (P = 0, 08) and of replenishment
ressures (P = 0, 06). A meaningful improvement of the right ven-
ricle function has been noted at 17,9% of patients. In univariate
nalysis, the heart rate < 76 bpms, the width of the QRS, a LVEF < 30,
% were predictive of improvement of the LVEF. The E/Ea ratio
as predictive of diastolic function improvement and no predic-
ive factor of improvement of the right ventricle function has been
ecovered.
onclusion.— The bisoprolol permitted to improve clinical,
unctional, echocardiographic parameters and to decrease the NT-
roBNP of meaningful way.
